Health Disparities and SARS-COV-2 Evolution: A Focused Viral Genomics Study
健康差异和 SARS-COV-2 进化:一项重点病毒基因组学研究
基本信息
- 批准号:10381371
- 负责人:
- 金额:$ 73.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-15 至 2022-08-04
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressAdherenceAmino AcidsAntibodiesAntiviral AgentsAreaAwarenessBioinformaticsBiologicalBody mass indexCLIA certifiedCOVID-19COVID-19 pandemicCOVID-19 patientCOVID-19 surveillanceCOVID-19 vaccineCerebrovascular DisordersChronicChronic DiseaseChronic Kidney FailureClassification SchemeClinicalClinical DataCommunitiesCommunity Health EducationCommunity OutreachDataData AnalyticsDiabetes MellitusDiffusionDropsEvolutionGenderGeneticGenetic VariationHealthcare SystemsHumanHypertensionImmune systemImmunityImmunosuppressive AgentsImpairmentIndividualInfectionInformation DisseminationInstitutionKnowledgeLaboratoriesLength of StayLiftingLinguisticsLouisianaMalignant NeoplasmsMethodsMinorityMolecular EpidemiologyMonoclonal AntibodiesMutationObesityOutcomeParticipantPathogenicityPatientsPatternPhylogenetic AnalysisPopulationPopulation SizesPreventive measureProbabilityProcessRenal dialysisReportingResource InformaticsSARS-CoV-2 genomeSARS-CoV-2 variantSeveritiesSymptomsTestingTimeTransplant RecipientsUnderinsuredUnderserved PopulationUninsuredVaccinatedVaccinationVaccinesVariantViralViral Drug ResistanceViral GenomeVirusVulnerable Populationsage groupbasebiomedical informaticsclinical phenotypecommunity engagementcomorbiditydesignepidemiologic datahealth disparityimmune clearanceimmunogenicimmunogenicityimprovedinnovationmodels and simulationnext generation sequencingoutreachpandemic diseasepressureprogramsracial and ethnicsequencing platformstudy populationtrendvariants of concernviral genomicsvirus genetics
项目摘要
Health Disparities and SARS-CoV-2 Evolution: A Focused Viral Genomics Study
Project Summary/Abstract
We hypothesize that prolonged COVID19 illness, re-infection, and/or post-vaccine infection in
patients with chronic conditions are associated with specific SARS-CoV-2 lineages or mutations,
and that increasing the awareness of the potential danger posed by variants of concern will
improve testing adherence and variant tracking. We propose to use our established FDA-
authorized COVID19 sequencing platform in combination with innovative data analytics and
clinical bioinformatics as well as our BMI and community engagement KCAs. Our proposal
addresses four of the priority areas indicated by NOT-GM-21-031, specifically:
• Are there different variants present in the study population, and how has the number of cases
caused by different variants changed over time in the study population?
• How are different variants distributed among different racial, ethnical, gender, and/or age
groups?
• Are specific variants associated with different levels of manifestation of COVID19 symptoms?
• Do vaccinated study participants still acquire the SARS-CoV-2 virus, and if so, what variants
do they carry?
We propose these Specific Aims:
Specific Aim 1. To improve surveillance of COVID19 by integrating SARS-CoV-2 sequencing and
clinical data with a focus on under-represented, vulnerable and remote populations. Using highly
automated processes, we will identify variants/mutations associated with clinical phenotypes,
including prolonged asymptomatic/antibody-positive individuals, re-infected, and vaccinated
populations. All trend data will be integrated in the AWS cloud where it can be accessed by
relevant stakeholders including testing and vaccine program partners.
Specific Aim 2. To develop and validate simulation models that incorporate SARS-CoV-2 genetic
data with clinical outcomes to predict COVID19 case severity in Louisiana by region as
vaccination levels increase.
Specific Aim 3. To design and deploy culturally and linguistically appropriate outreach material on
SARS-CoV-2 and determine whether increased knowledge of the potential danger of adaptive
mutations improves acceptance of testing and vaccination.
健康差异与SARS-CoV-2进化:一项针对性病毒基因组学研究
项目总结/摘要
我们假设,长期COVID 19疾病,再感染,和/或疫苗后感染,
患有慢性疾病的患者与特定的SARS-CoV-2谱系或突变有关,
提高对令人关切的变异体所构成的潜在危险的认识,
改进测试依从性和变体跟踪。我们建议使用我们现有的食品药品管理局-
授权的COVID 19测序平台结合创新的数据分析,
临床生物信息学以及我们的BMI和社区参与KCA。我们的建议
解决了NOT-GM-21-031中指出的四个优先领域,具体为:
·研究人群中是否存在不同的变异,病例数量如何
是由研究人群中随时间变化的不同变体引起的吗?
·不同的变体如何在不同的种族、民族、性别和/或年龄中分布
群组?
·特定变异是否与COVID 19症状的不同表现水平相关?
·接种疫苗的研究参与者是否仍会感染SARS-CoV-2病毒,如果是,是什么变种
他们携带?
我们提出这些具体目标:
具体目标1。通过整合SARS-CoV-2测序和
临床数据,重点关注代表性不足、弱势和偏远人群。使用高度
自动化过程,我们将识别与临床表型相关的变异/突变,
包括长期无症状/抗体阳性个体、再次感染和接种疫苗
人口。所有趋势数据都将集成到AWS云中,
包括检测和疫苗计划合作伙伴在内的相关利益攸关方。
具体目标2。开发并验证包含SARS-CoV-2基因的模拟模型
根据临床结局数据预测路易斯安那州各地区COVID 19病例的严重程度,
疫苗接种水平提高。
具体目标3。设计和部署在文化和语言上适当的宣传材料,
SARS-CoV-2,并确定是否增加了对适应性疾病潜在危险的认识
基因突变提高了检测和疫苗接种的可接受性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN P. KIRWAN其他文献
JOHN P. KIRWAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN P. KIRWAN', 18)}}的其他基金
Louisiana Clinical and Translational Science Center
路易斯安那州临床和转化科学中心
- 批准号:
10415589 - 财政年份:2021
- 资助金额:
$ 73.76万 - 项目类别:
Louisiana Clinical and Translational Science Center
路易斯安那州临床和转化科学中心
- 批准号:
10258534 - 财政年份:2020
- 资助金额:
$ 73.76万 - 项目类别:
Role and Regulation of Skeletal Muscle Mitochondrial Dynamics in Type 2 Diabetes
骨骼肌线粒体动力学在 2 型糖尿病中的作用和调节
- 批准号:
9767119 - 财政年份:2015
- 资助金额:
$ 73.76万 - 项目类别:
Role of the skeletal muscle/pancreatic axis in type 2 diabetes
骨骼肌/胰轴在 2 型糖尿病中的作用
- 批准号:
9014518 - 财政年份:2015
- 资助金额:
$ 73.76万 - 项目类别:
Role and Regulation of Skeletal Muscle Mitochondrial Dynamics in Type 2 Diabetes
骨骼肌线粒体动力学在 2 型糖尿病中的作用和调节
- 批准号:
9336293 - 财政年份:2015
- 资助金额:
$ 73.76万 - 项目类别:
Role of the skeletal muscle/pancreatic axis in type 2 diabetes
骨骼肌/胰轴在 2 型糖尿病中的作用
- 批准号:
8815628 - 财政年份:2015
- 资助金额:
$ 73.76万 - 项目类别:
Louisiana Clinical and Translational Science Center - N3C supplement
路易斯安那临床和转化科学中心 - N3C 补充品
- 批准号:
10884657 - 财政年份:2012
- 资助金额:
$ 73.76万 - 项目类别:
Louisiana Clinical and Translational Science Center
路易斯安那州临床和转化科学中心
- 批准号:
10677678 - 财政年份:2012
- 资助金额:
$ 73.76万 - 项目类别:
Louisiana Clinical and Translational Science Center
路易斯安那州临床和转化科学中心
- 批准号:
10513330 - 财政年份:2012
- 资助金额:
$ 73.76万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 73.76万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 73.76万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 73.76万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 73.76万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 73.76万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 73.76万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 73.76万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 73.76万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 73.76万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 73.76万 - 项目类别: